Imiquimod 5% cream

DRUG16 trials

Sponsors

Graceway Pharmaceuticals, LLC, The Hospital for Sick Children, St. Justine's Hospital, MEDA Pharma GmbH & Co. KG, Rigel Dermatology

Conditions

Actinic KeratosesAnogenital Human Papillomavirus InfectionBasal Cell CarcinomaCarcinoma, Basal CellCondyloma AnalCutaneous NeurofibromasGenital Wart Virus InfectionHemangioma, Capillary

Early Phase 1

Neoadjuvant Imiquimod Immunotherapy for Oral Cancer

CompletedNCT04883645

Medical University of South CarolinaOral Squamous Cell Carcinoma

Start: 2022-04-28End: 2024-07-31Updated: 2025-01-28

Phase 1

Topical Imiquimod 5% Cream for Treatment of Cutaneous Neurofibromas in Adults With Neurofibromatosis 1

CompletedNCT00865644

Massachusetts General HospitalCutaneous Neurofibromas, Neurofibromatosis Type 1

Start: 2009-03-31End: 2013-12-31Updated: 2017-01-10

Immunologic Profile of Chronically Photodamaged Skin

CompletedNCT02889159

University of MichiganNormal Skin, Photoaged Skin

Start: 2016-06-06End: 2023-02-23Updated: 2025-02-13

Phase 2

A Phase II Study of Imiquimod 5 % Cream for the Treatment of Hemangioma in Infancy

CompletedNCT00601016

St. Justine's HospitalHemangioma, Capillary

Start: 2005-03-31End: 2006-09-30Updated: 2008-01-25

Evaluation of VGX-3100 and Electroporation Alone or in Combination With Imiquimod for the Treatment of HPV-16 and/or HPV-18 Related Vulvar HSIL (Also Referred as: VIN 2 or VIN 3)

CompletedNCT03180684

Inovio PharmaceuticalsHuman Papillomavirus (HPV), Pre-cancerous Lesions of the Vulva, VIN2 +4

Start: 2017-08-31End: 2020-12-18Updated: 2023-08-25

Imiquimod for Preventing Keloid Recurrence

TerminatedNCT03760250

University of PennsylvaniaKeloid

Start: 2019-02-05End: 2020-09-01Updated: 2020-11-19

Phase 3

A Study to Evaluate the Effectiveness of Imiquimod 5% Cream for Basal Cell Carcinoma Recurrence

CompletedNCT00129519

Graceway Pharmaceuticals, LLCBasal Cell Carcinoma

Start: 2004-01-31End: 2006-01-31Updated: 2010-07-16

Imiquimod in Children With Plaque Morphea

CompletedNCT00147771

The Hospital for Sick ChildrenScleroderma, Localized

Start: 2005-09-30End: 2009-09-30Target: 10Updated: 2013-08-02

Open-label Study to Evaluate Clearance of Superficial Basal Cell Carcinoma After Use of Imiquimod 5% Cream

CompletedNCT00189306

Graceway Pharmaceuticals, LLCSuperficial Basal Cell Carcinoma

Start: 2001-03-31End: 2007-04-30Updated: 2010-08-10

Adjuvant Anal Imiquimod Therapy in Anal HPV-lesions: AdAM-trial

Medical University InnsbruckAnogenital Human Papillomavirus Infection, Condyloma Anal

Start: 2021-11-15End: 2024-11-15Target: 200Updated: 2020-09-23

Betaglucin 0.2% Versus Imiquimod 5% in Treatment of Ano-genital Warts: Combined Results From Triple Blind Controlled Study

Centro de Investigaciones Medicas y Ensayos Clinicos Dr Italo FabbriGenital Wart Virus Infection

Start: 2019-08-27End: 2020-05-20Target: 102Updated: 2020-02-05

Phase 4

Imiquimod 5% Cream in the Treatment of External Genital or Perianal Warts in HIV+ Patients

CompletedNCT00761371

MEDA Pharma GmbH & Co. KGWarts

Start: 2002-08-31End: 2004-02-29Updated: 2022-02-07

Topical Imiquimod Cream in Combination With Cryotherapy for the Treatment of Actinic Keratoses

CompletedNCT00774787

Rigel DermatologyActinic Keratoses

Start: 2008-10-31End: 2010-03-31Updated: 2016-11-07

Imiquimod 5% Cream for the Treatment of Periocular Basal Cell Carcinoma

University of Sao PauloCarcinoma, Basal Cell

Start: 2008-12-31End: 2013-02-28Target: 20Updated: 2012-06-13

Imiquimod Versus Photodynamic Therapy of Actinic Keratoses in Organ Transplant Recipients

TerminatedNCT01538901

Medical University of ViennaActinic Keratoses

Start: 2012-09-30End: 2014-09-30Updated: 2017-09-12

Unknown Phase

1-Year Follow up to the 1473-IMIQ Study

CompletedNCT00114023

Graceway Pharmaceuticals, LLCKeratosis

Start: 2005-01-31Target: 84Updated: 2007-02-19

Related Papers

Pilot clinical trial of neoadjuvant toll-like receptor 7 agonist (Imiquimod) immunotherapy in early-stage oral squamous cell carcinoma

Frontiers in Immunology2025-01-278 citations